The New-Delhi, India-based healthtech startup Qure.ai on Thursday raised INR 115 crore (around $0.224 million) from Sequoia India and MassMutual Ventures Southeast Asia.
The company leverages artificial intelligence to make healthcare more accessible and affordable. The AI-based solutions of Qure.ai enhance medical imaging accuracy to return better results in lesser time.
Qure.ai claims that their head-CT is the only solution in the healthcare industry that detects every critical brain abnormality on a head CT. The chest X-ray automation and interpretation solution accurately interprets chest X-rays to automatically generate X-ray interpretation reports, detect tuberculosis, lung collapses and cardiac disorders.
Sharing plans about the utilisation of funds, Prashant Warier, Co-founder & CEO of Qure.ai said…
“This funding round will allow us to further invest into R&D and to expand the reach of our solutions, accelerating our mission of delivering accessible and affordable healthcare to every human being,”
The company said its head-CT product is the only solution in the industry to detect every critical brain abnormality on a head CT.
Commenting on the investment round, Anjana Sasidharan, Principal at Sequoia Capital India said…
“Medical imaging is one of the fields in healthcare where there is enough digitized data to turn the promise of AI into a reality. The sophistication of Qure.ai’s algorithms and predictive analytics tools, coupled with their expert team of data scientists and physicians positions them very well versus their global competitors,”
Ryan Collins, Managing Director, MassMutual Ventures said…
“Very few companies in this category have achieved this level of both academic and real-world validation, and Qure.ai is leading across multiple use-cases and modalities,”
Qure.ai in numbers
Founded in 2016 by Prashant Warier and Dr. Pooja Rao, Qure.ai, present across over 20 countries and claims to have served over 600,000 patients through its solutions.
ⓘ Want to get your content featured on LAFFAZ? Submit your article.